Surface expression and functional characterization of α-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen, and convulxin

Blood

Volumn 95, Issue 5, 2000, Pages 1694-1702

  Alberio, L ^b   Safa, O ^b   Clemetson, K J ^b   Esmon, C T ^b   Dale, George L ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; CALCIMYCIN; COLLAGEN; MONOCLONAL ANTIBODY; THROMBIN;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

EID: 0034161567     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.5.1694.005k24_1694_1702     Document Type: Article

References (39)

1. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost. 1997;78:611.
2. Rosing J, van Rijn JL, Severs EM, van Dieijen G, Comfurius P, Zwaal RFA. The role of activated platelets in prothrombin and factor X activation. Blood. 1985;65:319.
3. Jesty J, Nemerson Y. The pathways of blood coagulation. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. New York, NY: McGraw-Hill; 1995:1227.
4. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RFA, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 1991;77:2641.
5. Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood. 1982;60:59.
6. Chesney CM, Pifer D, Colman RW. Subcellular localization and secretion of factor V from human platelets. Proc Natl Acad Sci U S A. 1981;78:5180.
7. Tracy PB, Giles AR, Mann KG, Eide LL, Hoogendoom H, Rivard GE. Factor V (Quebec): A bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest. 1984;74:1221.
8. Grigg AP, Dauer R, Thurlow PJ. Bleeding due to an acquired inhibitor of platelet associated factor V. Aust N Z J Med. 1989;19:310.
9. Nesheim ME, Nichols WL, Cole TL, et al. Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest. 1986:77:405.
10. Camire RM, Kalafatis M, Simioni P, Girolami A, Tracy PB. Platelet derived factor Va/VaLeiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood. 1998;91:2818.
11. Severs EM, Comfurius P, Zwaal RFA. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev. 1991;5:146.
12. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem. 1989;264:17,049.
13. Dachary-Prigent J. Freyssinet J-M, Pasquet J-M, Carron J-C, Nurden AT. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood. 1993;81:2554.
14. Polgar J, Clemetson JM, Kehrel BE, et al. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem. 1997;272:13,576.
15. Esmon CT, Esmon NL, Le Bonniec BF, Johnson AE. Protein C activation. Meth Enzymol. 1993;222:359.
16. Le Bonniec BF, Esmon CT. Glu-192 [to] Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc Natl Acad Sci USA. 1991;88:7371.
17. Le Bonniec BF, Guinto ER, Esmon CT. The role of calcium ions in factor X activation by thrombin E192Q. J Biol Chem. 1992;267:6970.
18. Smirnov MD, Safa O, Regan L, et al. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem. 1998;273:9031.
19. Esmon CT, Jackson CM. The factor V activating enzyme of Russell's viper venom. Thromb Res. 1973;2:509
20. McEver RP, Bennett EM, Martin MN. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies. J Biol Chem. 1983;258:5269.
21. Alberio L, Dale GL. Flow cytometric analysis of platelet activation by different collagen types present in the vessel wall. Br J Haematol. 1998;102:1212.
22. Safa O, Morrissey JH, Esmon CT, Esmon NL. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C. Biochem. 1999;38:1829.
23. Peng J, Friese P, Heilmann E, George JN, Burstein SA, Dale GL. Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood. 1994;83:161.
24. Viskup RW, Tracy PB, Mann KG. Isolation of human platelet factor V. Blood. 1987;69:1188.
25. Dale GL, Friese P, Hynes LA, Burstein SA. Demonstration that thiazole orange-positive platelets in the dog are less than twenty-four hours old. Blood. 1995;85:1822.
26. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol. 1995;23:996.
27. Rinder HM, Tracey JB, Recht M, et al. Differences in platelet α-granule release between normals and immune thrombocytopenic patients and be-tween young and old platelets. Thromb Haemost. 1998;80:457.
28. Nesheim ME, Furmaniak-Kazmierczak E, Henin C, Cote G. On the existence of platelet receptors tor factor V(a) and factor VIII(a). Thromb Haemost. 1993;70:80
29. Polgar J, Magnenat E, Wells TNC, Clemetson KJ. Platelet glycoprotein Ia* is the processed form of multimerin isolation and determination of N-terminal sequences of stored and released forms. Thromb Haemost. 1998;80:645.
30. Bienz D, Clemetson KJ. Human platelet glycoprotein Ia*: One component is only expressed on the surface of activated platelets and may be a granule constituent. J Biol Chem. 1989;264:507.
31. Hayward CPM, Smith JW, Horsewood P, Warkentin TE, Kelton JG. p-155, a multimeric platelet protein that is expressed on activated platelets. J Biol Chem. 1991;266:7114.
32. Hayward CPM, Furmaniak-Kazmierczak E, Cieutat AM, et al. Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granules. J Biol Chem. 1995;270:19,217.
33. Bouchard BA, Catcher CS, Thrash BR, Adida C, Tracy PB. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase catalyzed thrombin generation. J Biol Chem. 1997;272:9244.
34. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, et al. Cell derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation. 1997;96:3534.
35. Geiser T, Sturzenegger M, Genewein U, Haeberli A, Beer JH. Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli and platelet microparticles in patients with prosthetic heart valves. Stroke. 1998;29:1770.
36. Zwaal RFA, Comfurius P, Bevers EM. Platelet procoagulant activity and microvesicle formation: its putative role in hemostasis and thrombosis. Biochim Biophys Acta. 1992;1180:1.
37. Swords NA, Tracy PB, Mann KG. Intact platelet membranes, not platelet-released microvesicles, support the procoagulant activity of adherent platelets. Arteriosclerosis Thromb. 1993;13:1613.
38. Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med. 1972;287:155
39. Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfusion Med Rev, 1997;11:130.